
Barikind 4 Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Baricitinib (4mg)
Overview Barikind 4 Tablet
For hospitalized adults with COVID-19, Remdesivir treatment often includes the concomitant use of Barikind 4 Tablets. This medication may be administered with or without food, but consistent daily timing is recommended. Dosage is individualized, considering your health status and other medications. Always adhere to your physician's prescribed regimen; premature discontinuation may exacerbate your condition. Commonly reported side effects include upper respiratory tract infections, nausea, and viral illnesses; less frequent but potentially serious side effects such as gastrointestinal bleeding, blood clots, and cold sores may also occur, demanding immediate medical attention. Prior bloodwork may be necessary, and treatment should be deferred if you have any active infection. Pre-existing conditions, including tuberculosis, shingles, hepatic or renal impairment, hepatitis B or C, or a history of thromboembolism, require discussion with your doctor before commencing treatment. Barikind 4 Tablets can increase susceptibility to infection; therefore, minimize contact with individuals exhibiting contagious illnesses (e.g., influenza, measles, varicella). This medication is contraindicated in children under 18 and pregnant or breastfeeding individuals unless deemed medically necessary by your physician. Regular monitoring by your doctor is advisable.
Primary Ingredients of Barikind 4 Tablet
No text provided to rephrase.
Uses of Barikind 4 Tablet
Managing COVID-19 infection
Major Benefits of Barikind 4 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Barikind 4 Tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Barikind 4 Tablet:
- Upper respiratory tract infection
- Nausea
- Herpes virus infection
- Cold sores
- Viral infection
- Sore throat
How to use Barikind 4 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Barikind 4 Tablets can be consumed with or without food, though consistent timing is recommended.
How Barikind 4 Tablet works:
Barikind 4 Tablets employ Janus kinase (JAK) inhibition, specifically targeting JAK1 and JAK2 enzymes. This action disrupts the JAK-STAT signaling cascade—a crucial protein-cellular communication network governing immunity, cell proliferation, apoptosis, and oncogenesis.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Barikind 4 Tablet and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Using Barikind 4 Tablets during pregnancy is considered unsafe due to confirmed risks to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Barikind 4 Tablet while breastfeeding is likely inadvisable. Preliminary research in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Barikind 4 Tablet.
KidneyUNSAFE
The use of Barikind 4 Tablet is likely inadvisable for individuals with kidney impairment and should be avoided. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Barikind 4 Tablet is considered safe for patients with liver disease; no dosage modification is typically advised. However, its use in patients exhibiting severe liver disease is not recommended owing to insufficient data and clinical studies. Physician consultation is therefore crucial.
What if you forget to take Barikind 4 Tablet :
NA
Facts to Know About Barikind 4 Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrrolopyrimidine compound |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Behavior Class | JAK inhibitors |
